A study showed that MDE-derived miR-21, which participates in various processes of tumor progression, conferred cisplatin resistance in GC cells by suppressing cell apoptosis and enhancing the activation of PI3K/AKT signaling pathway via the downregulation of PTEN (56). The gene discussed is AKT1; the disease is gastric cancer.